STAPLED PEPTIDE Trademark

Trademark Overview


On Friday, August 21, 2009, a trademark application was filed for STAPLED PEPTIDE with the United States Patent and Trademark Office. The USPTO has given the STAPLED PEPTIDE trademark a serial number of 77810056. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 18, 2011. This trademark is owned by Aileron Therapeutics, Inc.. The STAPLED PEPTIDE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purpose...
stapled peptide

General Information


Serial Number77810056
Word MarkSTAPLED PEPTIDE
Filing DateFriday, August 21, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 18, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"PEPTIDE"
Goods and Servicespharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAileron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, January 18, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 18, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 22, 2010NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 22, 2010FINAL REFUSAL E-MAILED
Tuesday, June 22, 2010FINAL REFUSAL WRITTEN
Tuesday, June 22, 2010PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, June 21, 2010WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, June 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 8, 2010ASSIGNED TO LIE
Tuesday, May 25, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 21, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 21, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 21, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 25, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 25, 2009NON-FINAL ACTION E-MAILED
Wednesday, November 25, 2009NON-FINAL ACTION WRITTEN
Wednesday, November 25, 2009ASSIGNED TO EXAMINER
Tuesday, August 25, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 25, 2009NEW APPLICATION ENTERED IN TRAM